Researcher
Katty Zeven
- Keywords:Medicine
- Disciplines:Cancer therapy, Nuclear imaging, Cancer biology, Adaptive immunology
Affiliations
- Molecular Imaging and Therapy (Research group)
Member
From1 Jan 2023 → Today - Molecular Imaging and Therapy (Research group)
Member
From1 Jan 2024 → 31 Oct 2024 - Supporting clinical sciences (Department)
Member
From1 Nov 2020 → 31 Oct 2024 - Supporting clinical sciences (Department)
Member
From1 Sep 2019 → 31 Oct 2020 - Supporting clinical sciences (Department)
Member
From1 Sep 2019 → 31 Oct 2020 - Faculty of Medicine and Pharmacy (Faculty)
Member
From14 Aug 2019 → 27 Nov 2024 - Faculty of Medicine and Pharmacy (Faculty)
Member
From25 Sep 2017 → 26 Jun 2019
Projects
1 - 1 of 1
- CONVICT: sentencing Cancer cells to death through ONcolytic Virotherapy and modulation of the Immune Checkpoint TIGITFrom1 Nov 2020 → 31 Oct 2024Funding: FWO fellowships
Publications
1 - 8 of 8
- Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity(2024)
Authors: Fien Meeus, Cyprine Neba Funeh, Robin Maximilian Awad, Katty Zeven, Dorien Autaers, Ann De Becker, Ivan Van Riet, Cleo Goyvaerts, Sandra Tuyaerts, Bart Neyns, et al.
- Advancements in Nuclear Imaging Using radiolabeled Nanobody tracers to support Cancer Immunotherapy(2024)
Authors: Katty Zeven, Yoline Lauwers, Lynn De Mey, Jens Debacker, Tessa De Pauw, Timo W M De Groof, Nick Devoogdt
- Generation and Characterization of Novel Pan-Cancer Anti-uPAR Fluorescent Nanobodies as Tools for Image-Guided Surgery(2024)
Authors: Lukasz Mateusiak, Sam Floru, Timo W M De Groof, Janne Wouters, Noemi B Declerck, Pieterjan Debie, Simone Janssen, Katty Zeven, Karine Breckpot, Janik Puttemans, et al.
- In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4+ T cells(2023)
Authors: Robin Maximilian Awad, Yannick De Vlaeminck, Fien Meeus, Thomas Ertveldt, Katty Zeven, Hannelore Ceuppens, Cleo Goyvaerts, Magali Verdonck, Gustavo Salguero, Geert Raes, et al.
Pages: 1-13 - Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT(2023)
Authors: Katty Zeven, Timo W M De Groof, Hannelore Ceuppens, Robin Maximilian Awad, Thomas Ertveldt, Wout de Mey, Fien Meeus, Geert Raes, Karine Breckpot, Nick Devoogdt
- Emerging applications of nanobodies in cancer therapy(2022)
Authors: Robin Maximilian Awad, Fien Meeus, Hannelore Ceuppens, Thomas Ertveldt, Heleen Hanssens, Quentin Lecocq, Lukasz Mateusiak, Katty Zeven, Hana Valenta, Timo W M De Groof, et al.
Pages: 143-199 - Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade(2021)
Authors: Robin Maximilian Awad, Quentin Lecocq, Katty Zeven, Thomas Ertveldt, Lien De Beck, Hannelore Ceuppens, Katrijn Broos, Yannick De Vlaeminck, Cleo Goyvaerts, Magali Verdonck, et al.
Pages: 172-182 - Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use(2019)
Authors: Quentin Lecocq, Katty Zeven, Yannick De Vlaeminck, Sandrina Martens, Sam Massa, Cleo Goyvaerts, Geert Raes, Marleen Keyaerts, Karine Breckpot, Nick Devoogdt